MarketCap
Facebook
X
TelegramLand |
 Vereinigte Staaten |
IPO-Jahr |
2013 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
36.8 M |
Marktkapitalisierung |
$ 1.77 B |
EBITDA (LTM) |
$ 17.3 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Supernus Pharmaceuticals
SUPN
|
$ 40.79 | 0.22 % | $ 2.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Savara
SVRA
|
$ 4.53 | 7.23 % | $ 1.01 B | Nasdaq Global Select Market | USA |
 |
China SXT Pharmaceuticals
SXTC
|
$ 3.49 | -14.88 % | $ 2.37 M | Nasdaq Global Select Market |  China |
 |
Takeda Pharmaceutical Company Limited
TAK
|
$ 20.45 | 1.01 % | $ 32.3 B | NYSE |  Japan |
 |
Inozyme Pharma
INZY
|
- | - | $ 207 M | Nasdaq Global Select Market | USA |
 |
BioCardia
BCDA
|
$ 0.89 | -3.28 % | $ 5.93 M | Nasdaq Global Select Market | USA |
 |
CNS Pharmaceuticals
CNSP
|
$ 4.53 | -8.85 % | $ 2.01 M | Nasdaq Capital Market | USA |
 |
Cocrystal Pharma
COCP
|
$ 0.97 | 2.11 % | $ 11 M | Nasdaq Capital Market | USA |
 |
Protara Therapeutics
TARA
|
$ 2.36 | 1.07 % | $ 101 M | Nasdaq Global Market | USA |
 |
Tarsus Pharmaceuticals
TARS
|
$ 69.94 | 2.55 % | $ 2.92 B | Nasdaq Global Select Market | USA |
 |
Idera Pharmaceuticals
IDRA
|
- | -23.04 % | $ 26.6 M | Nasdaq Global Select Market | USA |
 |
Teva Pharmaceutical Industries Limited
TEVA
|
$ 40.03 | 1.57 % | $ 45.8 B | NYSE |  Israel |
 |
Collegium Pharmaceutical
COLL
|
$ 23.21 | 1.09 % | $ 735 M | Nasdaq Global Select Market | USA |
 |
NanoString Technologies
NSTG
|
- | -37.43 % | $ 5.1 M | Nasdaq Global Select Market | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
$ 87.25 | 1.62 % | $ 9.06 B | Nasdaq Capital Market,SPB | USA |
 |
TG Therapeutics
TGTX
|
$ 54.79 | 1.14 % | $ 7.91 B | Nasdaq Capital Market | USA |
 |
Humanigen
HGEN
|
- | -81.12 % | $ 4.28 M | Nasdaq Global Select Market | USA |
 |
Sorrento Therapeutics
SRNE
|
- | -29.58 % | $ 126 M | Nasdaq Global Select Market | USA |
 |
Surface Oncology
SURF
|
- | - | $ 59.7 M | Nasdaq Global Select Market | USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
$ 4.0 | -1.36 % | $ 53.3 M | Nasdaq Global Market | USA |
 |
Sierra Oncology
SRRA
|
- | -0.05 % | $ 1.34 B | Nasdaq Global Select Market |  Canada |
 |
Tonix Pharmaceuticals Holding Corp.
TNXP
|
$ 5.31 | 2.42 % | $ 45.2 M | Nasdaq Global Select Market | USA |
 |
Atea Pharmaceuticals
AVIR
|
$ 4.16 | 2.97 % | $ 339 M | Nasdaq Global Select Market | USA |
 |
Tenax Therapeutics
TENX
|
$ 1.65 | -4.07 % | $ 64.7 M | Nasdaq Global Select Market | USA |
 |
Vaccinex
VCNX
|
- | -61.37 % | $ 654 K | Nasdaq Global Select Market | USA |
 |
Trevi Therapeutics
TRVI
|
$ 12.51 | -0.83 % | $ 1.69 B | Nasdaq Global Market | USA |
 |
Nymox Pharmaceutical Corporation
NYMX
|
- | -19.68 % | $ 18.4 M | Nasdaq Capital Market | Canada |
 |
Akero Therapeutics
AKRO
|
- | - | $ 3.67 B | Nasdaq Global Select Market,SPB | USA |
 |
Taysha Gene Therapies
TSHA
|
$ 4.0 | 0.88 % | $ 1.28 B | Nasdaq Global Select Market | USA |
 |
Jounce Therapeutics
JNCE
|
- | - | $ 98.4 M | Nasdaq Global Select Market | USA |
 |
Verona Pharma plc
VRNA
|
- | - | $ 69.7 B | Nasdaq Global Select Market |  Britain |
 |
Corner Growth Acquisition Corp.
COOL
|
- | -0.89 % | $ 114 M | Nasdaq Global Select Market | USA |
 |
Acorda Therapeutics
ACOR
|
- | -24.86 % | $ 820 K | Nasdaq Global Select Market | USA |
 |
CRISPR Therapeutics AG
CRSP
|
$ 49.0 | -0.79 % | $ 4.41 B | Nasdaq Global Market,SPB |  Schweiz |
 |
Corvus Pharmaceuticals
CRVS
|
$ 10.44 | -0.9 % | $ 824 M | Nasdaq Global Market | USA |
 |
UroGen Pharma Ltd.
URGN
|
$ 34.05 | -1.29 % | $ 1.64 B | Nasdaq Global Select Market | Israel |
 |
Ampio Pharmaceuticals
AMPE
|
- | -11.43 % | $ 502 K | NYSE American | USA |
 |
United Therapeutics Corporation
UTHR
|
$ 593.02 | 0.94 % | $ 26.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Vericel Corporation
VCEL
|
$ 42.99 | 1.08 % | $ 2.16 B | Nasdaq Global Select Market,SPB | USA |
 |
Veracyte
VCYT
|
$ 48.22 | 0.61 % | $ 3.79 B | Nasdaq Global Market,SPB | USA |
|
Champions Oncology
CSBR
|
$ 4.82 | 2.12 % | $ 66.7 M | Nasdaq Capital Market | USA |
 |
Mersana Therapeutics
MRSN
|
- | - | $ 3.56 B | Nasdaq Global Select Market | USA |
 |
Vir Biotechnology
VIR
|
$ 11.02 | 4.27 % | $ 1.53 B | Nasdaq Global Select Market,SPB | USA |
 |
Viking Therapeutics
VKTX
|
$ 24.23 | -0.72 % | $ 2.73 B | Nasdaq Capital Market | USA |
 |
CymaBay Therapeutics
CBAY
|
- | - | $ 3.45 B | Nasdaq Global Select Market | USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
- | - | $ 384 M | Nasdaq Global Select Market | Britain |
 |
Cabaletta Bio
CABA
|
$ 1.34 | -9.18 % | $ 135 M | Nasdaq Global Select Market | USA |
 |
CytomX Therapeutics
CTMX
|
$ 2.23 | -4.09 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Vanda Pharmaceuticals
VNDA
|
$ 3.95 | -1.62 % | $ 233 M | Nasdaq Global Select Market,SPB | USA |
 |
Allakos
ALLK
|
- | - | $ 28.6 M | Nasdaq Global Select Market,SPB | USA |